168 related articles for article (PubMed ID: 38077404)
1. High-dimensional phenotyping of the peripheral immune response in community-acquired pneumonia.
Reijnders TDY; Schuurman AR; Verhoeff J; van den Braber M; Douma RA; Faber DR; Paul AGA; Wiersinga WJ; Saris A; Garcia Vallejo JJ; van der Poll T
Front Immunol; 2023; 14():1260283. PubMed ID: 38077404
[TBL] [Abstract][Full Text] [Related]
2. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
Schuurman AR; Reijnders TDY; Saris A; Ramirez Moral I; Schinkel M; de Brabander J; van Linge C; Vermeulen L; Scicluna BP; Wiersinga WJ; Vieira Braga FA; van der Poll T
Elife; 2021 Aug; 10():. PubMed ID: 34424199
[TBL] [Abstract][Full Text] [Related]
3. The host response in different aetiologies of community-acquired pneumonia.
Schuurman AR; Reijnders TDY; van Engelen TSR; Léopold V; de Brabander J; van Linge C; Schinkel M; Pereverzeva L; Haak BW; Brands X; Kanglie MMNP; van den Berk IAH; Douma RA; Faber DR; Nanayakkara PWB; Stoker J; Prins JM; Scicluna BP; Wiersinga WJ; van der Poll T
EBioMedicine; 2022 Jul; 81():104082. PubMed ID: 35660785
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Immune Suppression and Hyperinflammation in Patients With Community-Acquired Pneumonia.
Brands X; Haak BW; Klarenbeek AM; Otto NA; Faber DR; Lutter R; Scicluna BP; Wiersinga WJ; van der Poll T
Front Immunol; 2020; 11():796. PubMed ID: 32477337
[TBL] [Abstract][Full Text] [Related]
5. Comparison of systemic inflammatory profiles in COVID-19 and community-acquired pneumonia patients: a prospective cohort study.
Ibáñez-Prada ED; Fish M; Fuentes YV; Bustos IG; Serrano-Mayorga CC; Lozada J; Rynne J; Jennings A; Crispin AM; Santos AM; Londoño J; Shankar-Hari M; Reyes LF
Respir Res; 2023 Feb; 24(1):60. PubMed ID: 36814234
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of blood parameters for community-acquired pneumonia.
Huang Y; Liu A; Liang L; Jiang J; Luo H; Deng W; Lin G; Wu M; Li T; Jiang Y
Int Immunopharmacol; 2018 Nov; 64():10-15. PubMed ID: 30144639
[TBL] [Abstract][Full Text] [Related]
7. Changes in blood monocyte Toll-like receptor and serum surfactant protein A reveal a pathophysiological mechanism for community-acquired pneumonia in patients with type 2 diabetes.
Que Y; Shen X
Intern Med J; 2016 Feb; 46(2):213-9. PubMed ID: 26648341
[TBL] [Abstract][Full Text] [Related]
8. The distribution of myeloid-derived suppressor cells subsets and up-regulation of programmed death-1/PD-L1 axis in peripheral blood of adult CAP patients.
Gong H; Zhao J; Xu W; Wan Y; Mu X; Zhang M
PLoS One; 2023; 18(9):e0291455. PubMed ID: 37756307
[TBL] [Abstract][Full Text] [Related]
9. The circular RNA landscape in specific peripheral blood mononuclear cells of critically ill patients with sepsis.
Khan HN; Brands X; Aufiero S; Hoogendijk AJ; Klarenbeek AM; van Engelen TSR; Haak BW; van Vught LA; Horn J; Schultz MJ; Zwinderman AH; van der Poll T; Scicluna BP
Crit Care; 2020 Jul; 24(1):423. PubMed ID: 32660590
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia is associated with broad host response aberrations in community-acquired pneumonia.
Doeleman SE; Reijnders TDY; Joosten SCM; Schuurman AR; van Engelen TSR; Verhoeff J; Léopold V; Brands X; Haak BW; Prins JM; Kanglie MMNP; van den Berk IAH; Faber DR; Douma RA; Stoker J; Saris A; Garcia Vallejo JJ; Wiersinga WJ; van der Poll T
J Infect; 2024 Apr; 88(4):106131. PubMed ID: 38431153
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; Méndez R; Latorre A; Mengot N; Piqueras M; Reyes S; Moscardó A; Alonso R; Amara-Elori I; Menéndez R
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686001
[TBL] [Abstract][Full Text] [Related]
12. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.
Paats MS; Bergen IM; Hanselaar WE; van Zoelen EC; Verbrugh HA; Hoogsteden HC; van den Blink B; Hendriks RW; van der Eerden MM
Thorax; 2013 May; 68(5):468-74. PubMed ID: 23315492
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study.
Fierens J; De Bus L; Colpaert K; Boelens J; Gadeyne B; Decruyenaere J; Van Braeckel E; Depuydt P
Acta Clin Belg; 2022 Oct; 77(5):837-844. PubMed ID: 34709997
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients.
van Vught LA; Scicluna BP; Wiewel MA; Hoogendijk AJ; Klein Klouwenberg PM; Franitza M; Toliat MR; Nürnberg P; Cremer OL; Horn J; Schultz MJ; Bonten MM; van der Poll T
Am J Respir Crit Care Med; 2016 Dec; 194(11):1366-1374. PubMed ID: 27267747
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of circulating CXCR5-expressing CD8+ T-cells as a biomarker for bacterial infection in subjects with pneumonia.
Shen Y; Qu QX; Jin MN; Chen C
Respir Res; 2019 Mar; 20(1):54. PubMed ID: 30866951
[TBL] [Abstract][Full Text] [Related]
16. Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia.
Wallihan RG; Suárez NM; Cohen DM; Marcon M; Moore-Clingenpeel M; Mejias A; Ramilo O
Front Cell Infect Microbiol; 2018; 8():382. PubMed ID: 30425971
[No Abstract] [Full Text] [Related]
17. Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study.
Cangemi R; Calvieri C; Falcone M; Cipollone F; Ceccarelli G; Pignatelli P; D'Ardes D; Pirro M; Alessandri F; Lichtner M; D'Ettorre G; Oliva A; Aronica R; Rocco M; Venditti M; Romiti GF; Tiseo G; Taliani G; Menichetti F; Pugliese F; Mastroianni CM; Violi F
Thromb Haemost; 2022 Feb; 122(2):257-266. PubMed ID: 34758488
[TBL] [Abstract][Full Text] [Related]
18. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542
[TBL] [Abstract][Full Text] [Related]
19. Duration and magnitude of hypotension and monocyte deactivation in patients with community-acquired pneumonia.
Simon PM; Delude RL; Lee M; Kong L; Guzik LJ; Huang DT; Angus DC; Kellum JA;
Shock; 2011 Dec; 36(6):553-9. PubMed ID: 22080961
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
Arshad H; Alfonso JCL; Franke R; Michaelis K; Araujo L; Habib A; Zboromyrska Y; Lücke E; Strungaru E; Akmatov MK; Hatzikirou H; Meyer-Hermann M; Petersmann A; Nauck M; Brönstrup M; Bilitewski U; Abel L; Sievers J; Vila J; Illig T; Schreiber J; Pessler F
J Transl Med; 2019 Nov; 17(1):365. PubMed ID: 31711507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
